4 Intermittent fasting in the era of obesity pharmacotherapy From a therapeutic perspective, the controversy surrounding the health outcomes of IF should also be considered in the context of the evolving development of novel anti-obesity and anti-diabetic medications
Statements regarding food supplements have not been evaluated by the EFSA (European Food Safety Authority) and are not intended to diagnose, treat, cure, or prevent any disease or medical condition
95% CI, 1.1-1.13), gastritis (HR = 1.1
These habits not only support weight loss but also help manage possible side effects and maintain long-term results
Exclusion criteria included previous bariatric surgery, prior documented pregnancy or delivery events, incomplete BMI data and use of other anti-obesity medications (liraglutide, exenatide, dulaglutide, orlistat) (see codes in Supplementary Table S1)
Cabbage, including varieties like red cabbage and sauerkraut, offers concentrated glutathione support
